Pittenger & Anderson Inc’s Guardant Health GH Stock Holding History

Pittenger & Anderson Inc’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-55	Closed	-$4K	–	444
2022 Q1	$4K	Sell	55 -121	-69%	-$8.28K	﹤0.01%	396
2021 Q4	$18K	Sell	176 -14	-7%	-$1.45K	﹤0.01%	319
2021 Q3	$24K	Buy	190 +10	+6%	+$1.19K	﹤0.01%	311
2021 Q2	$22K	Buy	180 +54	+43%	+$7.26K	﹤0.01%	292
2021 Q1	$19K	Hold	126	–	–	﹤0.01%	293
2020 Q4	$16K	Buy	126 +85	+207%	+$9.78K	﹤0.01%	294
2020 Q3	$5K	Hold	41	–	–	﹤0.01%	321
2020 Q2	$3K	Hold	41	–	–	﹤0.01%	331
2020 Q1	$3K	Hold	41	–	–	﹤0.01%	319
2019 Q4	$3K	Buy	41 +11	+37%	+$793	﹤0.01%	342
2019 Q3	$2K	Hold	30	–	–	﹤0.01%	349
2019 Q2	$3K	Hold	30	–	–	﹤0.01%	349
2019 Q1	$2K	Buy	+30	New	+$1.66K	﹤0.01%	361

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Pittenger & Anderson Inc's GH Position: Q2 2022 in Review

Pittenger & Anderson Inc sold out of Guardant Health (GH) in Q2 2022, closing a stake of 55 shares — an estimated $4K sold.

Pittenger & Anderson Inc first reported a position in GH in Q1 2019 and held it in 13 quarters. The position peaked at $24K in Q3 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

Pittenger & Anderson Inc reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
Pittenger & Anderson Inc sold 55 Guardant Health shares in Q2 2022, an estimated $4K.
Pittenger & Anderson Inc first reported a position in Guardant Health in Q1 2019 and held it in 13 quarters.
Pittenger & Anderson Inc's Guardant Health position peaked at $24K in Q3 2021.
332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2022, filed 14 Jul 2022.